Literature DB >> 8852532

Citalopram in the treatment of early-onset panic disorder and school phobia.

U Lepola1, E Leinonen, H Koponen.   

Abstract

Panic Disorder (PD) is a common anxiety disorder, which has its onset relatively often during adolescence. Twenty-five percent of adult patients with PD have previously suffered from school phobia. In young patients it often represents a form of agoraphobia, although it may be present also in other psychiatric disorders which have their onset in young age. In this report we describe the results of 8 to 15-month citalopram treatment on three young patients with school phobia associated with PD. In our patients, low doses with citalopram were effective as in all patients the severity of school phobia decreased and the panic attacks disappeared. There were few drug-related side-effects as only one patient had mild headache at the beginning of the treatment. Our very preliminary results suggest that citalopram may be effective in school phobia related to PD. However, controlled studies are needed to demonstrate the safety, efficacy and appropriate length of citalopram treatment in childhood PD before it can be widely used in this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852532     DOI: 10.1055/s-2007-979539

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  3 in total

Review 1.  Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.

Authors:  Zhen Wang; Stephen P H Whiteside; Leslie Sim; Wigdan Farah; Allison S Morrow; Mouaz Alsawas; Patricia Barrionuevo; Mouaffaa Tello; Noor Asi; Bradley Beuschel; Lubna Daraz; Jehad Almasri; Feras Zaiem; Laura Larrea-Mantilla; Oscar J Ponce; Annie LeBlanc; Larry J Prokop; Mohammad Hassan Murad
Journal:  JAMA Pediatr       Date:  2017-11-01       Impact factor: 16.193

Review 2.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

3.  Synthesis and Antimicrobial Screening of Novel 4-Substituted Phenyl-5-[1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl]-2H-1,2,4-triazole-3-thiones.

Authors:  Namratha Bhandari; Santosh L Gaonkar
Journal:  Int Sch Res Notices       Date:  2014-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.